Design for Manufacturability (DFM) in Injection Molding for Medical Devices

The parts that cause the most trouble in production rarely look problematic on screen. A wall may be slightly too thick. A snap-fit may ignore material shrinkage. A surface finish may be specified for appearance instead of function. None of these necessarily flags as an error in CAD.

But how can you spot these potential issues early, before they derail your timeline and inflate costs?

If you’re a medical device design engineer working on injection-molded plastic components, this guide focuses on six DFM areas we recommend reviewing with your injection molder before tooling begins. Each one can affect mold design, part quality, inspection, and validation.

Design for Manufacturability means designing a part around how it will be tooled, molded, inspected, and repeated in production. In medical devices, this also includes manufacturing and regulatory constraints that do not always appear during prototyping.

In medical device molding, a part must also meet requirements for biocompatibility, sterilization, cleanability, and dimensional repeatability. A part may mold successfully in a prototype run but warp under ethylene oxide sterilization, absorb moisture, or lose dimensional stability in production. At that point, the issue is no longer just part design. It becomes a manufacturing risk.

These early design choices can also become part of the validation record. Geometry, material, and surface finish decisions must be documented, tested, and tied to acceptance criteria. Once validation has started, changing one of these decisions can affect the validation scope, documentation, and timeline.

From a molding standpoint, the goal is not simply to determine whether your part can be molded once. It is to determine whether it can be molded to specification, batch after batch, under actual production conditions.

In medical device plastic injection molding, the product designer and the molding partner are responsible for different parts of the same outcome.

The designer defines the part’s function, use environment, assembly needs, cosmetic expectations, material direction, and regulatory constraints. Their responsibility is to make sure the part supports the device’s intended use.

The injection molder reviews the part through the lens of the mold. They assess how the geometry will fill, how the material will shrink, where defects may form, and what the tooling will need to accommodate.

These conversations should happen before the design is frozen. When a designer and a molder review the part early, they can identify geometry, tooling, material, and tolerance issues before they become expensive changes or production delays.

Late design changes in medical device projects rarely affect only the mold.

A single geometry change can invalidate previous testing, require new documentation, and force parts of the validation process to be repeated. Depending on the project stage, these changes can also affect regulatory timelines, including FDA or CE submission planning.

Early DFM helps reduce the total cost of getting a part into production, not just the initial tooling cost. When geometry, material, tolerance, and surface finish issues are identified before the mold is built, the project is less likely to require mold modifications, additional sampling, or validation-related changes later.

For example, adjusting a wall thickness in CAD costs nothing, but modifying a hardened steel mold to fix a sink mark can cost thousands of dollars and weeks of delay. Early DFM gives the team a better chance of entering validation with a design that already reflects molding, inspection, and production constraints.

For your project, the practical value is fewer tooling revisions, fewer validation disruptions, and less risk of late-stage cost increases.

Tooling is where design changes become much more expensive. Once mold fabrication begins, changes to geometry, material, surface finish, or tolerances can affect cost, timing, sampling, and validation.

Many tooling revisions trace back to design decisions made before an injection molder reviewed the part. The six areas below are where those decisions tend to matter most.

Mechanical performance is only one part of material selection for medical device components.

Before you finalize the material, consider:

• Biocompatibility
• Sterilization compatibility
• Chemical exposure
• Cleanability
• Dimensional stability
• How the material behaves during molding

From a molding perspective, we also evaluate how the selected material will behave with your part geometry, expected shrinkage, tooling approach, and production requirements.

For example, certain resins, such as PEEK and polycarbonate, are common in medical applications, but they behave differently during cooling and shrinkage. Material selection must also support the device’s regulatory and validation requirements, including biocompatibility expectations under ISO 10993, where applicable.

Material decisions should be made early. Changing resin late in development can affect shrinkage, part dimensions, tooling assumptions, testing, and validation documentation. In some cases, it may also require mold modifications if the new material behaves differently enough in production.

In medical device design, features such as wall thickness, ribs, bosses, draft angles, and parting lines directly affect how a plastic part fills, cools, ejects, and performs in use.

When we review a part before tooling, some of the first geometry conditions we look at include:

• Uniform wall thickness (typically between 0.5mm and 4mm) is essential to avoid issues like sink marks, warping and uneven cooling.
• Ribs should be designed with a thickness of 50-60% of the wall thickness to avoid flow restrictions and ensure uniform filling and cooling, thereby minimizing defects such as short shots and sink marks.
• Bosses and snap-fit features should account for shrinkage, stress, and assembly fit.
• Draft angles should range between 1° to 3°, depending on the surface finish and material, to allow smooth ejection without damaging the part.
• Parting lines should be placed away from sealing surfaces, functional features, and visible cosmetic areas whenever possible.

As you develop the part in CAD, consider how these geometry decisions will affect molding. Complex geometries, such as undercuts or deep cavities, can increase tooling costs, cycle time, and sampling complexity.

Design complexity directly affects tooling costs, cycle time, and mold maintenance. Undercuts, deep cavities, and complex ejection systems can require side cores, slides, lifters, or multi-action mechanisms, which increase tooling costs.

In practice, undercuts often require slides or side actions, which add tooling cost and can extend the sampling process. Deep cavities or thin walls often require advanced cooling systems to ensure consistent cooling, further complicating mold design. In many projects, simplifying complex geometries upfront can save considerable time and cost.

Reviewing these features before tooling begins gives the design team and the plastic injection molding partner a chance to simplify where possible, protect critical functions, and reduce the risk of tooling changes after the mold has been built.

In medical device injection molding, flow behavior has a direct effect on part quality and repeatability. The part’s geometry influences how molten plastic fills, packs, and cools within the mold. Elements such as wall thickness, gate location, and venting must be optimized to avoid defects, including weld lines, air traps, and short shots.

You should understand how material viscosity, pressure, and geometry affect flow, especially in complex or thin-walled medical parts. Critical surfaces, cosmetic areas, sealing features, and dimensional requirements should be clearly identified before tooling begins.

Reviewing these details before mold design is finalized helps plastic injection molders place gates, vents, and cooling channels around the part’s actual functional requirements.

Tight tolerances on injection-molded medical parts are achievable, but they need to be justified. Specifying ±0.001″ across the board can increase tooling and part cost, complicate inspection, and extend validation timelines without always improving function.

Tolerances should reflect how the plastic material behaves during molding. Unlike precision-machined parts, injection-molded plastics shrink during cooling, which can affect dimensions. It’s essential to account for shrinkage rates and stack-up effects when setting tolerances.

Before tooling begins, identify which dimensions are truly critical, which ones govern assembly fit, and which ones can use standard commercial tolerances. Features such as snap-fits, living hinges, and press-fit bores are particularly sensitive to wall thickness and material shrinkage rates. In many projects, these features are designed without accounting for how the material flows into that geometry, and the first shots reveal the problem.

Surface finish specifications affect mold construction, material selection, ejection, cost, and validation scope. SPI finish grades are not interchangeable. A high-polish finish on a surface exposed to high ejection force, for example, can create maintenance or production issues.

Finishing requirements are sometimes driven solely by aesthetics, without considering parting line placement or texture depth relative to the draft angle. A minimum of 1.5 degrees of draft per 0.001″ of texture depth is a standard starting point. A finer finish than the part requires can add tooling cost without improving function. The finish should be tied to the part’s use, handling, cleaning, sealing, or cosmetic requirements before it is locked into the tool.

From a validation standpoint, locking in the surface finish early helps keep IQ, OQ, and PQ testing aligned with the approved design. A post-tooling change may require new documentation, additional testing, or partial revalidation, adding cost and delaying market entry.

Good DFM in medical device injection molding produces a part that can be molded, inspected, validated, and reproduced under real production conditions.

That means starting DFM conversations early, before the design is frozen and before a tool has been sourced. For this, you should involve your molder as a technical partner, not just as a vendor who receives a finished drawing. You should review the geometry, materials, tolerances, and surface expectations with production realities in mind, not just for prototype feasibility.

The six DFM areas covered in this guide are not independent. A decision made in one area routinely affects another. Material influences shrinkage, which affects tolerances. Geometry determines flow, which influences weld lines and fill behavior. Surface finish drives draft, which shapes ejection behavior.

By addressing these issues early, medical device design engineers are less likely to face tooling revisions, repeated sampling, validation delays, or production problems once the part moves beyond CAD and prototyping.

Before design freeze, a DFM review can help identify geometry, material, tolerance, and surface finish issues that may affect tooling or validation.

Reach out to PreciKam’s molding experts to review your medical device component before the design moves into tooling.